More importantly, the efficiency of ADH-1 in decreasing the tumor size and prolonging mouse survival time was better than those of anti-PD-1, anti-IDO-1 and anti-CTLA-4 when used individually or in combination (figure 7I, J). The gene discussed is CTLA4; the disease is neoplasm.